Track topics on Twitter Track topics that are important to you
The current 2017-18 flu season is a bad one. Hospitalization rates are now higher than in recent years at the same point, and infection rates are still rising. The best line of defense is the seasonal influenza vaccine. But H3N2 viruses, like the one that’s infecting many people this year, are particularly hard to defend […]
The vaccine shows better-than-expected effectiveness against the most common and most virulent strain of influenza in children under 9 years old.
Injecting mice with inactivated induced pluripotent stem cells launched a strong immune response against breast, lung, and skin cancers
The overall effectiveness of this season's influenza vaccine has been estimated at 36%, according to an analysis in MMWR. Researchers examined data on nearly 4600...
STAT Plus: Cancer cells and stem cells share some of the same molecules on their surfaces. And that could be a boon for immunotherapies.
FDA provides update on flu vaccines during this severe flu season
DUBLIN–(BUSINESS WIRE)–The “Drug Analysis: TAK-003” drug pipelines has been added to ResearchAndMarkets.com’s offering. TAK-003 (Takeda) is a needle-free, tetravalent live-attenuated vaccine currently in Phase II/III development in the US and dengue-endemic countries in Asia and Latin America, including Brazil, Colombia, … Continue reading → Cet article Gl...
DUBLIN–(BUSINESS WIRE)–The “Drug Analysis: TetraVax-DV” drug pipelines has been added to ResearchAndMarkets.com’s offering. TetraVax-DV is a lyophilized, tetravalent, live-attenuated chimeric vaccine currently in Phase II/III development. The viral strains were formulated by the US National Institutes of Health (NIH) and … Continue reading → Cet article Gl...
Stem cells and cancer cells have enough molecular similarities that the former can be used to trigger immunity against the latter.
Northwest Biotherapeutics said its trial of an experimental brain cancer treatment was ready to be analyzed a year ago. What happened to it?
Valneva Reports Strong 2017 Revenues Driven by Double Digit Product Sales Growth Strong sales performance in 2017 (unaudited) Total revenues of €109.8 million in 2017 (2016 - €97.9 million) representing year-on-year growth of 12% Product sales of €92.6 million in 2017 (2016 - €80.4 million) representing year-on-year growth of 15%, including IXIARO®/JESPECT® sales of €60....
1. No increased risk of incident epilepsy was seen among children who received influenza vaccination during the 2009-2010 influenza season in Norway. Evidence Rating Level: 2 (Good) Study Rundown: Previous studies suggest associations between febrile seizures and influenza infection, complex febrile seizures and epilepsy, and seizures (particularly febrile) and vaccination (including influenza vac...
Health workers resorted to using fractional doses of yellow fever vaccine in the midst of an outbreak. The fractional doses seem to have worked.
SummaryA vaccine refrigerator is a refrigeration unit designed specifically for storing vaccines and other temperaturesensitive medical supplies, most of which need to be held at temperatures lower than that of a conventional fridge. The unit provides extremely stable low temperatures to prevent degradation of vaccines and other products, along with options like alarms and backup power to provide ...
With the nation reeling from an historically bad influenza outbreak, the Centers for Disease Control and Prevention is preparing the public for a dismal efficacy estimate for the 2017-18 vaccine against the predominant H3N2 A flu strain.
Sanofi Pasteur has licensed SK Chemicals' mammalian cell culture platform for vaccine production in a deal worth up to $155m (â126m).
Extends ongoing collaboration with Bill & Melinda Gates Foundation with award of two new grants CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced the awarding of two new grants from the Bill & Melinda Gates Foundation. The programs will leverage CureVac’s RNActive® prophylactic...
Scancell has reported promising 5-year survival data for its cancer vaccine SCIB1, with a second trial expected to start later this year. Scancell has published data from its ongoing Phase I/II trial in patients with stage III and IV melanoma in the journal OncoImmunology. ... This awesome article British Cancer Vaccine Boosts 5-Year Survival in Late Stage Melanoma appeared first on Labiotech....
New study shows all-cause mortality is significantly lower when a child's most recent immunization is a measles vaccine
The report provides a comprehensive analysis of the BCG Vaccine industry market by types, applications, players and regions. This report also displays the production, Consumption, revenue, Gross margin, Cost, Gross, market share, CAGR, and Market influencing factors of the BCG Vaccine industry in USA, EU, China,India, Japan and other regions, and forecast to 2022, from 2017.Market Analysis by Play...
The report provides a comprehensive analysis of the Pneumococcal Vaccine industry market by types, applications, players and regions. This report also displays the production, Consumption, revenue, Gross margin, Cost, Gross, market share, CAGR, and Market influencing factors of the Pneumococcal Vaccine industry in USA, EU, China,India, Japan and other regions, and forecast to 2022, from 2017.Marke...